ADAM9 silencing inhibits breast tumor cell invasion in vitro

Biochimie

Volumn 95, Issue 7, 2013, Pages 1371-1378

  Micocci, Kelli Cristina ^a   Martin, Ana Carolina Baptista Moreno ^a   Montenegro, Cyntia De Freitas ^a   Durante, Araceli Cristina ^a   Pouliot, Normand ^b   Cominetti, Márcia Regina ^a,c   Selistre De Araujo, Heloisa Sobreiro ^a  

^a Rodovia Washington Luís   (Brazil)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Departamento de Gerontologia   (Brazil)

Author keywords

ADAM9; Cancer; Cell adhesion; Disintegrin; Integrin; Metastasis; RNA silencing

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE 9 PROTEIN; ADAM PROTEIN; GELATINASE A; GELATINASE B; MATRIGEL; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CELL ADHESION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; MOLECULAR CLONING; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR CELL;

ADAM PROTEINS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84878545072     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.03.001     Document Type: Article

References (48)

1. R.O. Hynes Integrins: versatility, modulation, and signaling in cell adhesion Cell 69 1992 11 25
2. S.H. Lo, and L.B. Chen Focal adhesion as a signal transduction organelle Cancer Metastasis Rev. 13 1994 9 24
3. S.E. LaFlamme, and K.L. Auer Integrin signaling Semin. Cancer Biol. 7 1996 111 118
4. I.D. Campbell, and M.J. Humphries Integrin structure, activation, and interactions Cold Spring Harb. Perspect. Biol. 3 2011 1 14
5. R.L. Juliano, and J.A. Varner Adhesion molecules in cancer: the role of integrins Curr. Opin. Cell. Biol. 5 1993 812 818
6. T. Klein, and R. Bischoff Active metalloproteases of the A disintegrin and metalloprotease (ADAM) family: biological function and structure J. Proteome Res. 10 2011 17 33
7. N. Rocks, G. Paulissen, M. El Hour, F. Quesada, C. Crahay, M. Gueders, J.M. Foidart, A. Noel, and D. Cataldo Emerging roles of ADAM and ADAMTS metalloproteinases in cancer Biochimie 90 2008 369 379
8. T.G. Wolfsberg, P. Primakoff, D.G. Myles, and J.M. White ADAM, a novel family of membrane proteins containing A disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions J. Cell. Biol. 131 1995 275 278
9. D. Nath, P.M. Slocombe, A. Webster, P.E. Stephens, A.J. Docherty, and G. Murphy Meltrin gamma (ADAM-9) mediates cellular adhesion through alpha(6)beta(1)integrin, leading to a marked induction of fibroblast cell motility J. Cell Sci. 113 2000 2319 2328
10. M. Zhou, R. Graham, G. Russell, and P.I. Croucher MDC-9 (ADAM-9/meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin Biochem. Biophys. Res. Commun. 280 2001 574 580
11. M.R. Cominetti, A.C. Martin, J.U. Ribeiro, I. Djaafri, F. Fauvel-Lafeve, M. Crepin, and H.S. Selistre-de-Araujo Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions Biochimie 91 2009 1045 1052
12. R.M. Mahimkar, O. Visaya, A.S. Pollock, and D.H. Lovett The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins Biochem. J. 385 2005 461 468
13. P. Zigrino, J. Steiger, J.W. Fox, S. Loffek, A. Schild, R. Nischt, and C. Mauch Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration J. Biol. Chem. 282 2007 30785 30793
14. P. Zigrino, R. Nischt, and C. Mauch The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts J. Biol. Chem. 286 2011 6801 6807
15. F.R. Fritzsche, K. Wassermann, M. Jung, A. Tolle, I. Kristiansen, M. Lein, M. Johannsen, M. Dietel, K. Jung, and G. Kristiansen ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression BMC Cancer 8 2008 179
16. F.R. Fritzsche, M. Jung, A. Tolle, P. Wild, A. Hartmann, K. Wassermann, A. Rabien, M. Lein, M. Dietel, C. Pilarsky, D. Calvano, R. Grutzmann, K. Jung, and G. Kristiansen ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer Eur. Urol. 2007
17. C. O'Shea, N. McKie, Y. Buggy, C. Duggan, A.D. Hill, E. McDermott, N. O'Higgins, and M.J. Duffy Expression of ADAM-9 mRNA and protein in human breast cancer Int. J. Cancer 105 2003 754 761
18. A. Tannapfel, K. Anhalt, P. Hausermann, F. Sommerer, M. Benicke, D. Uhlmann, H. Witzigmann, J. Hauss, and C. Wittekind Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays J. Pathol. 201 2003 238 249
19. K. Tao, N. Qian, Y. Tang, Z. Ti, W. Song, D. Cao, and K. Dou Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis Jpn. J. Clin. Oncol. 40 2010 645 651
20. R. Grutzmann, J. Luttges, B. Sipos, O. Ammerpohl, F. Dobrowolski, I. Alldinger, S. Kersting, D. Ockert, R. Koch, H. Kalthoff, H.K. Schackert, H.D. Saeger, G. Kloppel, and C. Pilarsky ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma Br. J. Cancer 90 2004 1053 1058
21. S. Carl-McGrath, U. Lendeckel, M. Ebert, A. Roessner, and C. Rocken The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer Int. J. Oncol. 26 2005 17 24
22. A. Zubel, C. Flechtenmacher, L. Edler, and A. Alonso Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix Gynecol. Oncol. 114 2009 332 336
23. Q. Xu, X. Liu, Y. Cai, Y. Yu, and W. Chen RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells Tumour Biol. 31 2010 217 224
24. P. Zigrino, C. Mauch, J.W. Fox, and R. Nischt Adam-9 expression and regulation in human skin melanoma and melanoma cell lines Int. J. Cancer 116 2005 853 859
25. L. Peduto, V.E. Reuter, D.R. Shaffer, H.I. Scher, and C.P. Blobel Critical function for ADAM9 in mouse prostate cancer Cancer Res. 65 2005 9312 9319
26. A.I. Evangelou, S.F. Winter, W.J. Huss, R.A. Bok, and N.M. Greenberg Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype J. Cell. Biochem. 91 2004 671 683
27. B. Naimi, A. Latil, G. Fournier, P. Mangin, O. Cussenot, and P. Berthon Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate Prostate 52 2002 245 252
28. A. Matsubara, M. Kan, S. Feng, and W.L. McKeehan Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2 Cancer Res. 58 1998 1509 1514
29. N. Torring, L.V. Jensen, J.G. Wen, F.B. Sorensen, J.C. Djurhuus, and E. Nexo Chronic treatment with epidermal growth factor induces growth of the rat ventral prostate Scand. J. Urol. Nephrol. 35 2001 339 344
30. N. Hotoda, H. Koike, N. Sasagawa, and S. Ishiura A secreted form of human ADAM9 has an alpha-secretase activity for APP Biochem. Biophys. Res. Commun. 293 2002 800 805
31. A. Mazzocca, R. Coppari, R. De Franco, J.Y. Cho, T.A. Libermann, M. Pinzani, and A. Toker A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions Cancer Res. 65 2005 4728 4738
32. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
33. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
34. P.Y. Yue, E.P. Leung, N.K. Mak, and R.N. Wong A simplified method for quantifying cell migration/wound healing in 96-well plates J. Biomol. Screen. 15 2010 427 433
35. J.P. Cleutjens, J.C. Kandala, E. Guarda, R.V. Guntaka, and K.T. Weber Regulation of collagen degradation in the rat myocardium after infarction J. Mol. Cell. Cardiol. 27 1995 1281 1292
36. J.D. Hood, and D.A. Cheresh Role of integrins in cell invasion and migration Nat. Rev. Cancer 2 2002 91 100
37. S.M. Pontier, and W.J. Muller Integrins in breast cancer dormancy APMIS 116 2008 677 684
38. S. Mochizuki, and Y. Okada ADAMs in cancer cell proliferation and progression Cancer Sci. 98 2007 621 628
39. J.L. Klessner, B.V. Desai, E.V. Amargo, S. Getsios, and K.J. Green EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2 Mol. Biol. Cell. 20 2009 328 337
40. Y. Shintani, S. Higashiyama, M. Ohta, H. Hirabayashi, S. Yamamoto, T. Yoshimasu, H. Matsuda, and N. Matsuura Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis Cancer Res. 64 2004 4190 4196
41. J.L. Fry, and A. Toker Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration Cancer Res. 70 2010 8187 8198
42. A. Gschwind, S. Hart, O.M. Fischer, and A. Ullrich TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells EMBO J. 22 2003 2411 2421
43. Q. Zhang, S.M. Thomas, V.W. Lui, S. Xi, J.M. Siegfried, H. Fan, T.E. Smithgall, G.B. Mills, and J.R. Grandis Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation Proc. Natl. Acad. Sci. U. S. A. 103 2006 6901 6906
44. Y. Izumi, M. Hirata, H. Hasuwa, R. Iwamoto, T. Umata, K. Miyado, Y. Tamai, T. Kurisaki, A. Sehara-Fujisawa, S. Ohno, and E. Mekada A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor EMBO J. 17 1998 7260 7272
45. L.C. Bridges, and R.D. Bowditch ADAM-integrin interactions: potential integrin regulated ectodomain shedding activity Curr. Pharm. Des. 11 2005 837 847
46. J.M. White, L.C. Bridges, D.W. Desimone, M. Tomczuk, and T.G. Wolfsberg The ADAM Family of Proteases: Proteases in Biology and Disease vol. 4 2005 Springer The Netherlands
47. R.M. Mahimkar, W.H. Baricos, O. Visaya, A.S. Pollock, and D.H. Lovett Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney J. Am. Soc. Nephrol. 11 2000 595 603
48. S. Hamada, K. Satoh, W. Fujibuchi, M. Hirota, A. Kanno, J. Unno, A. Masamune, K. Kikuta, K. Kume, and T. Shimosegawa MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9 Mol. Cancer Res. 10 2012 3 10